Related Experiment Video
Updated: Jul 12, 2025
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
Abiraterone-Induced Endocrinopathies.
Scarlett Decamps1,2, Rita Lis1,2, Preethika Ekanayake1,2
1Division of Endocrinology, Diabetes and Metabolism, University of California, San Diego, 9350 Campus Point Drive, La Jolla, CA 92037, USA.
JCEM Case Reports
|November 1, 2023
Summary
Abiraterone treatment for prostate cancer can cause endocrine side effects like mineralocorticoid excess and adrenal insufficiency. This case series highlights their diagnosis and management in patients receiving abiraterone and prednisone.
Area of Science:
- Endocrinology
- Oncology
- Pharmacology
Background:
- Abiraterone acetate, a CYP17A1 inhibitor, improves survival in prostate cancer patients.
- Its endocrine side effects, particularly mineralocorticoid excess and adrenal insufficiency, are not well-documented in endocrinology literature.
Observation:
- This case series details three prostate cancer patients treated with abiraterone and prednisone.
- These patients exhibited endocrine complications including mineralocorticoid excess and secondary adrenal insufficiency.
Findings:
- The study focuses on the diagnostic challenges and management strategies for these specific abiraterone-induced endocrine side effects.
- It underscores the importance of recognizing and addressing these adverse events.
Implications:
- Findings suggest a need for increased awareness and proactive monitoring of endocrine function in patients on abiraterone therapy.
- This research contributes to a better understanding of abiraterone's endocrinological impact, aiding clinical practice.
Related Concept Videos
01:20Disorders of the Male Reproductive System
429
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
429
01:27Adrenal Gland Disorders
1.6K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.6K
01:29Acute Kidney Injury II: Pathophysiology
9
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
9
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
01:23Infertility in Males
275
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
275
01:25Antihypertensive Drugs: Direct Renin Inhibitors
648
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
648